e-learning
resources
Virtual 2020
Pre-Congress Content
Chronic lung diseases: novel methods, diagnostics and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Proteomic changes in respiratory tract lining fluid associated with smoking
S. Kokelj (Gothenburg, Sweden), J. Östling (Gothenburg, Sweden), B. Georgi (Gothenburg, Sweden), H. Olsson (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden)
Source:
Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Session:
Chronic lung diseases: novel methods, diagnostics and biomarkers
Session type:
E-poster session
Number:
323
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kokelj (Gothenburg, Sweden), J. Östling (Gothenburg, Sweden), B. Georgi (Gothenburg, Sweden), H. Olsson (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden). Late Breaking Abstract - Proteomic changes in respiratory tract lining fluid associated with smoking. 323
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Risk factors associated with the development of interstitial lung abnormalities
Related content which might interest you:
Late Breaking Abstract - Aging change the protein-profile of lining fluid from small airways
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Late Breaking Abstract - EvA consortium: bronchial brush bacterial load is associated with airway remodelling in mild-to-moderate COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017
Late Breaking Abstract - Microbiota and lower respiratory tract infections in children: a matched case-control study
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Late Breaking Abstract - Detection of small airway obstruction patterns in forced oscillometry(FO) and spirometry using artificial neural networks
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018
Late Breaking Abstract: Molecular phenotyping of asthma: Airflow obstruction and loss of asthma control with viral upper respiratory tract infections (URI) as characteristics of "TH2-high" asthma
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Late Breaking Abstract - Overlap of SGRQ and CAT-defined chronic mucus hypersecretion in the SPIROMICS cohort: implications for digital health
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid
Source: International Congress 2019 – New towards old therapies in airway diseases
Year: 2019
Late Breaking Abstract - Airway sensory innervation is increased in chronic cough
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Assessment of a ciliary transport protein in airway cells reveals novel pattern in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
Late Breaking Abstract: Detecting peripheral airway closure in airway disease by fluctuation analysis
Source: Annual Congress 2010 - Spotlight on lung function
Year: 2010
Late Breaking Abstract - Characteristics of macrophagal formula and cytokine spectrum of the bronchoalveolar lavage fluid in patients with newly diagnosed and those with recurring sarcoidosis of respiratory apparatus.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Late Breaking Abstract - The effect of altering gut microbiota on the development of pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019
Late Breaking Abstract - External humidification does not alleviate human epithelial inflammation after CPAP therapy
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept